Eunice Yang, MD
Cardiovascular Disease · Fairfax, VANPI 1114221942
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (49.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Abbott at 41.2% of the total. Reporting peaked in 2021 at $12,693 and has fallen 83.2% since, to $2,130 in 2025. Among cardiovascular disease clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 180 payments — averaging $173.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$13K
- Boston Scientific$11K
- Medtronic$5K
- Medical Device Business Services, Inc.$1K
- Biosense Webster, Inc.$748
- Biotronik Inc.$286
- plus $234 from 3 others
Across 4 payments — averaging $25,878 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$56K
- Biosense Webster, Inc.$48K
What the payments were for
- Grants$15,37549%
- Travel & lodging$7,05323%
- Food & beverage$8,35327%
- Education$4011%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 87 | $12,837 |
| Boston Scientific | 14 | $10,702 |
| Medtronic(2 entities) | 44 | $5,175 |
| Medical Device Business Services, Inc. | 4 | $1,199 |
| Biosense Webster, Inc. | 16 | $748 |
| Biotronik Inc. | 9 | $286 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $155 |
| Johnson & Johnson | 3 | $52 |
| Kestra Medical Technology Services, Inc. | 1 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL BRADY$5,000
- EMBLEM S ICD ELECTRODE DELIVERY SYSTEM$5,000
- ENSITE PRECISION$3,221
- Carto 3$1,421
- AVEIR$1,330
- Ensite Cardiac Mapping System$1,271
- AZURE XT DR MRI SURESCAN$310
- GENERAL - THERAPIES$263
- SelectSecure$253
- AFFERA MAPPING SYSTEM$192
- AGILIS$159
- ACCENT$157
- STEALTHSTATION S8 PLATFORM$145
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$141
- Micra$137
- Quadra Allure MP RF CRT Pacemkr$133
- ENSITE$125
- Confirm Rx$122
How this compares
$31,182 in reported general payments places this provider in the 90th percentile of 548 cardiovascular disease providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 57 | $55,185 |
| XareltoRivaroxaban | 26 | $20,516 |
| Amiodarone Hcl | 37 | $711 |
| Metoprolol Succinate | 27 | $607 |
| Flecainide Acetate | 22 | $543 |
| Pantoprazole Sodium | 12 | $136 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $52 | $20,51626 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 548 cardiovascular disease providers in Virginia.
Other cardiovascular disease in Fairfax
- Abbas EmaminiaFairfax$22K
- George VetrovecRichmond$2.3M
- Hamid TaheriManassas$501K
- Cyrus HadadiNorfolk$360K
- Michael AyersCharlottesville$305K
- David LimCharlottesville$264K
- Alexander TruesdellFalls Church$167K
- Antonio AbbateCharlottesville$161K
- Christopher OconnorFalls Church$161K
- Roberta ChapmanGloucester$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.